Cargando…
SAT524 Relaxin: A Novel Marker for Pro-Tumoral Thyroid Cancer Microenvironment?
Disclosure: A. Kotwal: None. R.G. Bennett: None. B. Swanson: None. W. Goldner: None. A. Yuil-Valdes: None. N. Whiteman: None. O. Shats: None. Background: Differentiated thyroid cancer (DTC) generally has a favorable prognosis, however, 30% have recurrence and progression hence there is a critical ne...
Autores principales: | Kotwal, Anupam, Bennett, Robert G, Swanson, Benjamin, Goldner, Whitney, Yuil-Valdes, Ana, Whiteman, Nicholas, Shats, Oleg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553651/ http://dx.doi.org/10.1210/jendso/bvad114.1996 |
Ejemplares similares
-
RF11 | PSAT272 Suppressive Tumor Immune Microenvironment is Associated with Aggressive Differentiated Thyroid Cancer
por: Kotwal, Anupam, et al.
Publicado: (2022) -
SAT510 I-131 Therapy with Dosimetry for Advanced Thyroid Carcinoma: Recombinant TSH vs Thyroid Hormone Withdrawal
por: Awad, Dana, et al.
Publicado: (2023) -
MON-518 Institutional Experience with Cytologically Indeterminate Thyroid Nodules: No Molecular Testing Versus Afirma Gene Expression Classifier or Genomic Sequencing Classifier
por: Polavarapu, Preethi, et al.
Publicado: (2020) -
Impaired Sleep Influences Health Care Related Quality of Life in Patients With Well Differentiated Thyroid Carcinoma
por: Disanti, Domenic, et al.
Publicado: (2021) -
ODP524 Thyroid Storm Precipitated by COVID-19 Infection: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)